Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Ramacieri

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Biofactors (Oxford, England)|February 14, 2024
The functional roles of S-adenosyl-methionine and S-adenosyl-homocysteine and their involvement in trisomy 21Maria Caracausi, Giuseppe Ramacieri, Francesca Catapano, et al.
Cancers|May 14, 2025
Correction: Guarneri et al. Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma. <i>Cancers</i> 2025, <i>17</i>, 167Valeria Guarneri, Elisabetta Loggi, Giuseppe Ramacieri, et al.
Human Genomics|May 2, 2021
The transcriptome profile of human trisomy 21 blood cellsFrancesca Antonaros, Rossella Zenatelli, Giulia Guerri, et al.
Physiological Genomics|July 23, 2025
Metabolic and genetic imbalance of the homocysteine-methionine cycle in trisomy 21Beatrice Vione, Bassam Lajin, Francesca Antonaros, et al.
BMC Medical Genomics|December 21, 2022
Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype associationMaria Chiara Pelleri, Chiara Locatelli, Teresa Mattina, et al.
Frontiers in Medicine|July 3, 2024
Corrigendum: One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: relation to chromosomal dosageBeatrice Vione, Giuseppe Ramacieri, Giacomo Zavaroni, et al.
Frontiers in Medicine|December 19, 2022
One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosageBeatrice Vione, Giuseppe Ramacieri, Giacomo Zavaroni, et al.
Frontiers in Immunology|May 2, 2024
Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effectGiuseppe Ramacieri, Chiara Locatelli, Michela Semprini, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 29, 2025
One‑carbon pathway gene expression analyses in blood samples of subjects with trisomy 21Beatrice Vione, Alessandro Maria Gaudesi, Francesca Antonaros, et al.
Scientific Reports|February 25, 2022
A reassessment of Jackson's checklist and identification of two Down syndrome sub-phenotypesChiara Locatelli, Sara Onnivello, Caterina Gori, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Biofactors (Oxford, England)|February 14, 2024
The functional roles of S-adenosyl-methionine and S-adenosyl-homocysteine and their involvement in trisomy 21Maria Caracausi, Giuseppe Ramacieri, Francesca Catapano, et al.
Cancers|May 14, 2025
Correction: Guarneri et al. Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma. <i>Cancers</i> 2025, <i>17</i>, 167Valeria Guarneri, Elisabetta Loggi, Giuseppe Ramacieri, et al.
Human Genomics|May 2, 2021
The transcriptome profile of human trisomy 21 blood cellsFrancesca Antonaros, Rossella Zenatelli, Giulia Guerri, et al.
Physiological Genomics|July 23, 2025
Metabolic and genetic imbalance of the homocysteine-methionine cycle in trisomy 21Beatrice Vione, Bassam Lajin, Francesca Antonaros, et al.
BMC Medical Genomics|December 21, 2022
Partial trisomy 21 with or without highly restricted Down syndrome critical region (HR-DSCR): report of two new cases and reanalysis of the genotype-phenotype associationMaria Chiara Pelleri, Chiara Locatelli, Teresa Mattina, et al.
Frontiers in Medicine|July 3, 2024
Corrigendum: One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: relation to chromosomal dosageBeatrice Vione, Giuseppe Ramacieri, Giacomo Zavaroni, et al.
Frontiers in Medicine|December 19, 2022
One-carbon pathway metabolites are altered in the plasma of subjects with Down syndrome: Relation to chromosomal dosageBeatrice Vione, Giuseppe Ramacieri, Giacomo Zavaroni, et al.
Frontiers in Immunology|May 2, 2024
Zinc metabolism and its role in immunity status in subjects with trisomy 21: chromosomal dosage effectGiuseppe Ramacieri, Chiara Locatelli, Michela Semprini, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 29, 2025
One‑carbon pathway gene expression analyses in blood samples of subjects with trisomy 21Beatrice Vione, Alessandro Maria Gaudesi, Francesca Antonaros, et al.
Scientific Reports|February 25, 2022
A reassessment of Jackson's checklist and identification of two Down syndrome sub-phenotypesChiara Locatelli, Sara Onnivello, Caterina Gori, et al.
Pageof 3